Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profound Medical (PROF) Net Income towards Common Stockholders (2024 - 2025)

Profound Medical has reported Net Income towards Common Stockholders over the past 2 years, most recently at $77.0 million for Q4 2025.

  • Quarterly results put Net Income towards Common Stockholders at $77.0 million for Q4 2025, up 51.85% from a year ago — trailing twelve months through Dec 2025 was $42.6 million (up 53.04% YoY), and the annual figure for FY2025 was $42.6 million, up 53.04%.
  • Net Income towards Common Stockholders for Q4 2025 was $77.0 million at Profound Medical, up from -$8.0 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for PROF hit a ceiling of $77.0 million in Q4 2025 and a floor of -$15.7 million in Q2 2025.